We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+7.23%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.7B
AUM Growth
-$2.27B
Cap. Flow
-$3.12B
Cap. Flow %
-17.63%
Top 10 Hldgs %
15.77%
Holding
1,947
New
557
Increased
335
Reduced
444
Closed
606

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$113M
2
BERY
Berry Global Group, Inc.
BERY
+$106M
3
MRK icon
Merck
MRK
+$95.9M
4
BIDU icon
Baidu
BIDU
+$85.8M
5
IQV icon
IQVIA
IQV
+$83.1M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$229M
2
LVS icon
Las Vegas Sands
LVS
+$150M
3
BABA icon
Alibaba
BABA
+$131M
4
C icon
Citigroup
C
+$130M
5
MU icon
Micron Technology
MU
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 25.57%
2 Technology 15.56%
3 Consumer Discretionary 13.67%
4 Industrials 10.53%
5 Financials 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.82T
$500M 2.83%
5,075,375
-366,326
-7% -$35.5M
BSX icon
2
Boston Scientific
BSX
$67.7B
$293M 1.65%
8,948,629
-2,567,644
-22% -$77.4M
DGX icon
3
Quest Diagnostics
DGX
$26.8B
$292M 1.65%
2,658,130
+214,446
+9% +$22.3M
META icon
4
Meta Platforms (Facebook)
META
$1.47T
$272M 1.54%
1,401,223
-497,765
-26% -$89.9M
ZTS icon
5
Zoetis
ZTS
$31.7B
$270M 1.52%
3,168,080
+58,549
+2% +$4.94M
SPGI icon
6
S&P Global
SPGI
$131B
$266M 1.5%
1,305,895
-348,506
-21% -$68.8M
UNH icon
7
UnitedHealth
UNH
$355B
$241M 1.36%
983,254
+126,006
+15% +$30.3M
VRTX icon
8
Vertex Pharmaceuticals
VRTX
$138B
$236M 1.33%
1,387,800
+727,532
+110% +$113M
SEE
9
DELISTED
Sealed Air
SEE
$226M 1.28%
5,334,072
+1,074,609
+25% +$47.2M
ABMD
10
DELISTED
Abiomed Inc
ABMD
$195M 1.1%
475,505
-61,737
-11% -$22.4M
CSGP icon
11
CoStar Group
CSGP
$13.1B
$194M 1.1%
4,708,210
-412,160
-8% -$15.9M
CSL icon
12
Carlisle Companies
CSL
$14.1B
$189M 1.07%
1,743,816
+561,234
+47% +$59.4M
A icon
13
Agilent Technologies
A
$43.3B
$183M 1.04%
2,965,320
-77,107
-3% -$5.03M
BERY
14
DELISTED
Berry Global Group, Inc.
BERY
$174M 0.98%
4,127,186
+2,285,273
+124% +$106M
GPN icon
15
Global Payments
GPN
$24.6B
$168M 0.95%
1,506,607
+463,060
+44% +$52.3M
PFE icon
16
Pfizer
PFE
$159B
$157M 0.88%
4,550,201
-234,843
-5% -$8.03M
PTC icon
17
PTC
PTC
$17.2B
$154M 0.87%
1,646,772
-200,604
-11% -$17.3M
CBOE icon
18
Cboe Global Markets
CBOE
$32.8B
$152M 0.86%
1,463,354
+214,432
+17% +$22.7M
EA
19
DELISTED
Electronic Arts
EA
$141M 0.79%
997,308
+31,341
+3% +$4.07M
USFD icon
20
US Foods
USFD
$23.2B
$131M 0.74%
3,462,342
+157,570
+5% +$5.58M
DHR icon
21
Danaher
DHR
$152B
$130M 0.73%
1,484,451
+110,101
+8% +$9.81M
ATO icon
22
Atmos Energy
ATO
$28.2B
$128M 0.72%
1,417,083
+225,465
+19% +$19.5M
MCD icon
23
McDonald's
MCD
$187B
$127M 0.72%
812,402
-109,541
-12% -$17.8M
ALXN
24
DELISTED
Alexion Pharmaceuticals
ALXN
$125M 0.7%
1,005,169
-79,722
-7% -$9.32M
TFX icon
25
Teleflex
TFX
$5.91B
$122M 0.69%
456,107
+129,455
+40% +$34.7M
1
2 3 4 5

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2018 Portfolio in Review

As of Q2 2018, Marshall Wace North America held 1,947 positions worth $17.7B, down 11% from $20B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America withdrew a net $3.12B in Q2 2018, closing 606 positions and reducing 444 holdings. Its most notable exit was Time Warner Inc, an estimated $63.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in IQVIA worth $83.1M.

  • Marshall Wace North America's largest Q2 2018 buy was IQVIA: 832,159 shares worth $83.1M.
  • Marshall Wace North America added most to Vertex Pharmaceuticals in Q2 2018, an estimated $113M increase.
  • Marshall Wace North America's biggest Q2 2018 reduction was Johnson & Johnson, cutting an estimated $229M.
  • Marshall Wace North America fully exited Time Warner Inc in Q2 2018, selling an estimated $63.3M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $17.7B portfolio in Q2 2018.
  • Marshall Wace North America opened 557 new positions and closed 606 in Q2 2018.
  • Marshall Wace North America's portfolio value fell 11% quarter-over-quarter to $17.7B.

Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.